TNSN88013A1 - Interleukine - 3 humaine et ses muteines - Google Patents

Interleukine - 3 humaine et ses muteines

Info

Publication number
TNSN88013A1
TNSN88013A1 TNTNSN88013A TNSN88013A TNSN88013A1 TN SN88013 A1 TNSN88013 A1 TN SN88013A1 TN TNSN88013 A TNTNSN88013 A TN TNSN88013A TN SN88013 A TNSN88013 A TN SN88013A TN SN88013 A1 TNSN88013 A1 TN SN88013A1
Authority
TN
Tunisia
Prior art keywords
muteins
human
interleukine
nucleic acids
acids encoding
Prior art date
Application number
TNTNSN88013A
Other languages
English (en)
Inventor
Otsuka Takeshi
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of TNSN88013A1 publication Critical patent/TNSN88013A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CETTE INVENTION CONCERNE DES MEDIATEURS PROTEINES DU DEVELOPPEMENT DU SYSTEME HEMATOPOIETIQUE AINSI QU'AUX ACIDES NUCLEIQUES LES CODANT. PLUS PARTICULIEREMENT, L'INVENTION SE RAPPORTE A UNE VARIANTE DE L'INTERLEUKINE-3 HUMAINE, A SES MUTEINES ET AUX ACIDES NUCLEIQUES LES CODANT.
TNTNSN88013A 1987-02-18 1988-02-17 Interleukine - 3 humaine et ses muteines TNSN88013A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1607987A 1987-02-18 1987-02-18

Publications (1)

Publication Number Publication Date
TNSN88013A1 true TNSN88013A1 (fr) 1990-07-10

Family

ID=21775278

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN88013A TNSN88013A1 (fr) 1987-02-18 1988-02-17 Interleukine - 3 humaine et ses muteines

Country Status (16)

Country Link
EP (2) EP0355093A1 (fr)
JP (1) JPH02500328A (fr)
KR (1) KR890700608A (fr)
CN (1) CN88100685A (fr)
AR (1) AR243240A1 (fr)
AU (1) AU626789B2 (fr)
FI (1) FI893872A (fr)
HU (1) HU204890B (fr)
IL (1) IL85444A0 (fr)
MY (1) MY102806A (fr)
NZ (1) NZ223551A (fr)
OA (1) OA09736A (fr)
PT (1) PT86772B (fr)
TN (1) TNSN88013A1 (fr)
WO (1) WO1988006161A1 (fr)
ZA (1) ZA881109B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
AU1496688A (en) * 1987-01-20 1988-08-10 Immunex Corporation Human interleukin-3 proteins
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
EP0425536A4 (en) * 1988-07-20 1992-01-02 Immunex Corporation Nonglycosylated human interleukin-3 compositions
US5128450A (en) * 1989-06-30 1992-07-07 Urdal David L Nonglycosylated human interleukin-3 analog proteins
ES2106017T3 (es) * 1989-08-14 1997-11-01 Gist Brocades Nv Mutantes de interleucina-3 humana.
US5516512A (en) * 1989-08-14 1996-05-14 Gist-Brocades, N.V. N- and C-terminal truncation and deletion mutants of human interleukin-3
US5108910A (en) * 1989-08-22 1992-04-28 Immunex Corporation DNA sequences encoding fusion proteins comprising GM-CSF and IL-3
JP3115318B2 (ja) * 1989-08-22 2000-12-04 イミュネックス・コーポレーション Ｇｍ―ｃｓｆ及びｉｌ―３を含む融合タンパク質
US5073627A (en) * 1989-08-22 1991-12-17 Immunex Corporation Fusion proteins comprising GM-CSF and IL-3
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
AU668364B2 (en) * 1991-10-07 1996-05-02 Medvet Science Pty. Ltd. Human IL-3 variants
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
EP0672145B1 (fr) 1992-11-24 2003-04-23 G.D. Searle & Co. Polypeptides a mutations multiples d'interleukine-3
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
RO120579B1 (ro) 1995-10-04 2006-04-28 Immunex Corporation Utilizarea ligandului flt3
US6670323B1 (en) 1999-11-12 2003-12-30 Baxter International, Inc. Reduced side-effect hemoglobin compositions
WO2006079169A1 (fr) * 2005-01-25 2006-08-03 Apollo Life Sciences Limited Gm-csf, il-3, il-4, il-5 choisis en fonction de parametres et leurs chimeres dans des applications therapeutiques et diagnostiques
EA033803B1 (ru) 2012-02-07 2019-11-27 Global Bio Therapeutics Inc Способ доставки нуклеиновых кислот с разделением, их композиции и использование
EP3030163B1 (fr) 2013-08-08 2019-03-20 Global Bio Therapeutics, Inc. Dispositif de serrage pour procédures mini-invasives
CN112195177B (zh) * 2020-10-28 2021-08-06 上海慕柏生物医学科技有限公司 一种核酸提取方法及试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60207594A (ja) * 1984-03-30 1985-10-19 Ajinomoto Co Inc ヒトインタ−ロイキン３の製造方法
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
WO1988004691A1 (fr) * 1986-12-16 1988-06-30 Gist-Brocades N.V. Clonage et expression moleculaires d'il-3 humaine

Also Published As

Publication number Publication date
AU1429488A (en) 1988-09-14
KR890700608A (ko) 1989-04-26
PT86772B (pt) 1992-05-29
EP0355093A1 (fr) 1990-02-28
AU626789B2 (en) 1992-08-13
WO1988006161A1 (fr) 1988-08-25
OA09736A (en) 1993-11-30
CN88100685A (zh) 1988-12-14
JPH02500328A (ja) 1990-02-08
MY102806A (en) 1992-11-30
FI893872A0 (fi) 1989-08-17
PT86772A (pt) 1988-03-01
HUT50872A (en) 1990-03-28
EP0282185A1 (fr) 1988-09-14
FI893872A (fi) 1989-08-17
NZ223551A (en) 1991-02-26
IL85444A0 (en) 1988-07-31
HU204890B (en) 1992-02-28
AR243240A1 (es) 1993-07-30
ZA881109B (en) 1988-08-17

Similar Documents

Publication Publication Date Title
TNSN88013A1 (fr) Interleukine - 3 humaine et ses muteines
ES2107041T3 (es) Variantes de activador de plasminogeno tisular obtenidos por glicosilacion, que presentan propiedades terapeuticas.
FI864654A (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
HK1013806A1 (en) Antibody purification
ATE88352T1 (de) Humanes relaxinpraeparat.
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
AU573523B2 (en) Functional human urokinase proteins
FI904851A0 (fi) Radiomaerkta antikoagulantpeptider.
IL72985A0 (en) Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it
BG101832A (en) Methods and materials for attributing plant resistance to diseases
IL93756A (en) Purification of recombinant human interleukin-3 and muteins thereof
DE69333412D1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
IT1270618B (it) Proteine ad attivita' antitumorale
DE3855080T2 (de) Synoviale phospholipasen
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
CZ28395A3 (en) Therapeutic composition containing whey protein concentrate
TNSN86154A1 (fr) Procede pour la preparation de cefodizime
KR950702207A (ko) Tlp 복합체에 대한 항원성 부위와 이의 항체(antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them)
ATE191923T1 (de) Interleukine-6 mutante mit verbesserter biologischer aktivität im vergleich zu wildtyp il-6
FR2361412A1 (fr) Systeme enzymatique scindant le fibrinogene
DE59208025D1 (de) Neue thrombininhibitorische proteine aus landblutegeln
ATE249837T1 (de) Caspase 8-inhibitoren zur immunsuppression
IT1233005B (it) Anticorpo umano monoclonale, composizione terapeutica che lo contiene linea cellulare capace di produrre l'anticorpo, procedimento per la sua produzione
ATE231887T1 (de) Protein mit anti-tumorwirkung
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein